Quintiles Information Library Custom Feed

Optimizing Clinical Development Sourcing

Tue, 01 May 2012 15:52:24 -0400

The US Affiliate of a top 10 European based pharma company came to the realization that their clinical development sourcing model had evolved within its late stage clinical operations function. Download the PDF

Clinical Development Health Check Diagnostic

Tue, 03 Apr 2012 00:00:00 -0400

How Do You Manage the Health of Your Clinical Development Processes and Effectively Measure Performance, Control Risk, and Demonstrate Value? Download the PDF

Cancer Treatments and the Search for Value

Mon, 02 Apr 2012 15:12:25 -0400

Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer

Accelerating Success in Oncology

Fri, 09 Mar 2012 09:26:52 -0400

New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity Download the PDF

Reinventing Biopharma

Wed, 01 Feb 2012 17:07:14 -0400

The biopharmaceutical industry today is facing a multifaceted “value challenge.” Download the PDF

ASCO 2012 – Accelerating Investigator Success in Oncology Trials

Wed, 11 Jan 2012 17:33:31 -0400

Quintiles will have an exhibit

Harish Dave Discusses ASH 2011

Thu, 08 Dec 2011 14:16:12 -0400

Harish Dave discusses the American Society of Hematology annual meeting.

Quintiles Sells Minority Interest in Invida

Tue, 15 Nov 2011 16:31:22 -0400

November 15, 2011 – Quintiles has sold its minority interest in Invida, an Asia Pacific commercial solutions joint venture, to the Italy-based Menarini Group, which is acquiring Invida in its entirety.

Multi-Channel Strategy

Wed, 09 Nov 2011 11:32:16 -0400

Rethinking the Real Points of Power Today, pharmaceutical and biotech companies relying on a conventional communication strategy aimed squarely and exclusively at physicians find themselves Download the PDF

Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.

Wed, 19 Oct 2011 12:30:00 -0400

October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).

Quintiles Acquires VCG & Associates and VCG Bio

Wed, 19 Oct 2011 08:30:00 -0400

October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

Quintiles Names New Global Head of Clinical & Data Operations

Thu, 06 Oct 2011 06:00:00 -0400

October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

Quintiles Addresses Key Considerations for Successful Biosimilar Development

Fri, 30 Sep 2011 14:53:19 -0400

September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

An Integrated Approach to Biosimilar Development & Commercialization

Thu, 29 Sep 2011 00:00:00 -0400

As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. Download the PDF

Improving Adherence

Wed, 21 Sep 2011 15:15:16 -0400

Newly diagnosed diabetics have a critical need for disease and drug education. But medical professionals lack the time. Clinical Educators can fill the gap. Download the PDF

Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage

Mon, 19 Sep 2011 06:00:00 -0400

September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.

Quintiles, Kadrige Open E-Solutions Operation in the US

Tue, 02 Aug 2011 09:07:36 -0400

August 2, 2011 – Quintiles and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of the first Kadrige office in the U.S.

A Focus on CNS

Fri, 01 Jul 2011 15:20:45 -0400

Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. Download the PDF

The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

Thu, 23 Jun 2011 14:33:45 -0400

In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. Download the PDF

Product Solutions

Mon, 16 May 2011 13:43:27 -0400

Product Solutions give pharma the insights needed to better gauge and drive the likelihood of a new product’s success from both clinical and commercial perspectives. Download the PDF

Quintiles and Population Genetics Technologies Partner

Mon, 16 May 2011 00:00:00 -0400

May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

Dr. Frank Massam

Fri, 13 May 2011 22:01:05 -0400

Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

New Healthcare Architecture to Maximize Vaccine Coverage Rates

Tue, 19 Apr 2011 12:48:05 -0400

Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine.

Commercial Solutions from Quintiles Canada

Mon, 18 Apr 2011 10:42:34 -0400

A conversation with Ian McBeath, General Manager, Commercial Solutions, Quintiles Canada, in Canadian Pharmaceutical Marketing magazine. Download the PDF

Quintiles Named a Preferred Provider to Global Health Product Development Partnership Consortium

Fri, 25 Mar 2011 07:18:56 -0400

March 25, 2011 – Quintiles has been named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs).

Biomarkers in Alzheimers Disease

Thu, 17 Mar 2011 09:06:55 -0400

The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. Download the PDF

Late Phase Research

Mon, 14 Mar 2011 14:27:58 -0400

Integrated solutions to define, demonstrate and communicate product value Download the PDF

Asia is Key to Driving Innovation in Drug Development and Overcoming Industry Challenges

Sun, 13 Mar 2011 00:00:00 -0400

March 13, 2011 – Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products, while emerging Asian companies seek new capabilities to globalize products.

Asia

Tue, 08 Mar 2011 19:00:00 -0400

This paper examines new development models as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to globalize products.

Deploying Clinical Trial Educators to Increase Clinical Trial Recruitment

Tue, 01 Feb 2011 11:16:58 -0400

In the February 2011 issue of the ACRP Monitor experts from Quintiles explain the importance of Clinical Trial Educators (CTEs) and their role in clinical Download the PDF

Oncology Commercialization Strategies conferences - Nicole Connelly

Mon, 31 Jan 2011 16:33:02 -0400

Stakeholder Focus in Early Oncology Commercialization

QUINTILES APPOINTS VINCENT AURENTZ TO LEAD CUSTOMER SOLUTIONS BUSINESS

Thu, 16 Dec 2010 09:00:00 -0400

December 16, 2010 - – Quintiles announced the appointment of Vincent Aurentz as Executive Vice President, Customer Solutions Business, to head a newly formed unit of dedicated customer teams that will deliver customized solutions across Quintiles’ global businesses.

Consulting – Breakthrough Thinking Built on Experience

Tue, 23 Nov 2010 13:36:29 -0400

Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today. Download the PDF

2010 Executive Vision Forum Insight Report

Thu, 18 Nov 2010 11:43:48 -0400

The 2010 forum presented a venue for executives and key opinion leaders to discuss and debate the converging forces now reshaping the industry.

QUINTILES AND KADRIGE PARTNER TO IMPROVE COMMERCIALIZATION OF PHARMACEUTICAL BRANDS

Tue, 16 Nov 2010 09:00:00 -0400

November 16, 2010 – Quintiles, and Kadrige, announce a global alliance that brings innovative models to physician detailing to help biotech and pharmaceutical companies increase productivity, overcome complexity and more efficiently demonstrate value for their therapies.

QUINTILES WINS SCRIP AWARDS ‘BEST CLINICAL RESEARCH ORGANIZATION’ FOR SECOND CONSECUTIVE YEAR

Wed, 10 Nov 2010 14:25:12 -0400

November 9, 2010 - For the second consecutive year, Quintiles has received Scrip Awards Best Clinical Research Organization honors based upon judging by an independent panel of prestigious life sciences experts.

Exclusive Report From Scientific American

Tue, 09 Nov 2010 08:55:28 -0400

In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

Healthcare's Future Tools

Mon, 08 Nov 2010 11:22:22 -0400

Beyond Genomics. The knowledge gained in mapping the genome is producing more tools and new ways of understanding how the human body works. See what's in store in this exclusive report.

Oncology Drug Development and Value-Based Medicine

Fri, 05 Nov 2010 14:57:57 -0400

This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. Download the PDF

Pharmacobiomics and Infectious Disease: Progress and Opportunities

Tue, 02 Nov 2010 08:35:43 -0400

Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits. Download the PDF

QUINTILES UNVEILS GLOBAL SERVICE OPERATIONS CENTER

Thu, 21 Oct 2010 17:27:25 -0400

October 22, 2010 - Quintiles announced the official opening of its new Global Information Technology (IT) Service Operations Center in Bangalore, India providing intelligent monitoring, control and triage of system events across Quintiles’ technology cloud.

Podcast: Clinical Development of Cancer Drugs in China

Mon, 18 Oct 2010 11:34:18 -0400

Hear exclusive interviews with Quintiles's experts, Christopher Ung, Patty James and Harish Dave on their recent participation at the 13th Annual Chinese Society of Clinical Oncology

From Biomarkers to Diagnostics - The Road to Success

Mon, 18 Oct 2010 10:43:12 -0400

In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity. Download the PDF

Advancing Clinical Research in Alzheimer's Disease

Mon, 18 Oct 2010 10:13:05 -0400

This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010. Download the PDF

EXAMINING REAL-TIME DATA TO IMPROVE THE QUALITY AND EFFICIENCY OF DRUG DEVELOPMENT

Wed, 13 Oct 2010 06:00:00 -0400

October 13, 2010 – White Paper authors explore how real-time data can enhance patient safety, strengthen quality and accelerate development timelines.

Patient-Centric Services

Mon, 11 Oct 2010 14:52:09 -0400

Just as payers are growing in influence, all roads are pointing back to the patient more directly and acutely. Quintiles Patient-Centric Services can maximize the value of your brands. Download the PDF

Is a REMS Request from FDA More Likely for Drugs & Biologics Indicated for Pediatric Use?

Fri, 08 Oct 2010 08:15:13 -0400

Is a REMS Request From FDA More Likely For Drugs and Biologics Indicated for Pediatric Use?

Management of Tissue Specimens for Oncology Drug Development in China

Fri, 01 Oct 2010 11:07:10 -0400

Download Patty James of Quintiles recent presentation Management of Tissue Specimens for Oncology Drug Development in China from the Clinical Development of Cancer Drugs in China

Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries

Fri, 01 Oct 2010 10:58:33 -0400

Download Christopher Ung of Quintiles recent presentation, Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries from the Clinical Development of Cancer Drugs in China Download the PDF

New Global Trends in Novel Oncology Drug Development

Fri, 01 Oct 2010 10:37:43 -0400

Download Harish Dave, MD, MBA of Quintiles recent presentation New Global Trends in Novel Oncology Drug Development from the Clinical Development of Cancer Drugs

Personalized Anti-Cancer Therapy Development in China

Fri, 01 Oct 2010 10:17:16 -0400

Download the slides from Michael Shi, M.D. of Novartis recent presentation, Personalized Anti-Cancer Therapy Development in China from the Clinical Development of Cancer Drugs in China

QUINTILES, HKPI, RAMCO ANNOUNCE JOINT VENTURE IN EGYPT

Wed, 29 Sep 2010 08:58:07 -0400

September 29, 2010 - Quintiles, Health Kare Pharma International (HKPI), and Ramco Import and Export today announced the formation of a joint venture to provide commercialization services in Egypt.

Advancing Oncology Care Through Innovative Treatment Approaches

Wed, 22 Sep 2010 08:19:57 -0400

In this new white paper, Quintiles’ oncology experts Harish Dave and Eric Groves summarize the new findings and promising results presented at the June ASCO 2010 meeting. Download the PDF

Closing Summary

Tue, 21 Sep 2010 16:41:42 -0400

Watch the video from Roza Hayduk, MD of Quintiles closing summary from the Quintiles Symposium, Navigating the Future Challenges in Alzheimer's Disease Trials at ICAD 2010.

Panel Discussion

Tue, 21 Sep 2010 16:35:20 -0400

Watch the video of the panel discussion from the Quintiles Symposium Navigating the Future Challenges in Alzheimer's Disease Trials at ICAD 2010.

Can Innovative Trial Designs Improve Success Rates of Future AD Clinical Trials

Tue, 21 Sep 2010 16:27:33 -0400

Download the slides from Paul Aisen, MD University of California, San Diego recent presentation, Can Innovative Trial Designs Improve Success Rates of Future AD Clinical Trials

Can Innovative Trial Designs Improve Success Rates of Future AD Clinical Trials

Tue, 21 Sep 2010 16:17:25 -0400

Watch the video of Paul Aisen, MD of University of California, San Diego recent presentation Can Innovative Trial Design Improve Success Rates of Future AD Clinical Trials from the Quintiles Symposium at ICAD 2010

Behavior as an Outcome in Disease Modifying AD Trials

Tue, 21 Sep 2010 16:07:30 -0400

Download the slides from Jeffrey Cummings, MD Cleveland Clinic recent presentation, Behavior as an Outcome in Disease Modifying AD Trials from the Quintiles Symposium at ICAD 2010

Jeffrey Cummings, M.D.

Tue, 21 Sep 2010 15:11:50 -0400

Jeffrey Cummings, MD Professor of Neurotherapeutics and Drug Development Cleveland Clinic Lerner College of Medicine Director, Cleveland Clinic Lou Ruvo Center for Brain Health Jeffrey

The Evolving Role of Neuroimaging in Future AD Clinical Trials

Tue, 21 Sep 2010 15:01:20 -0400

Download the slides from Philip Scheltens, MD VU Medical Center, Amsterdam recent presentation, The Evolving Role of Neuroimaging in Future AD Clinical Trials

The Evolving Role of Neuroimaging in Future AD Clinical Trials

Tue, 21 Sep 2010 14:48:33 -0400

Watch the video of Philip Scheltens's, MD of VU Medical Center recent presentation, The Evolving Role of Neuroimaging in Future AD Clinical Trials from the Quintiles Symposium at ICAD 2010.

Can Biomarkers Enhance Success Rates in Future AD Clinical Trials

Tue, 21 Sep 2010 14:37:47 -0400

Download the slides from Eric Siemers, MD of Eli Lilly and Company recent presentation, Can Biomarkers Enhance Success Rates in Future AD Clinical Trials from

Welcome and Introduction

Tue, 21 Sep 2010 14:17:17 -0400

Download the slides from Amir Kalali, MD Quintiles as he welcomes attendees to the Quintiles Symposium, Navigating the Future Challenges in Alzheimer's Disease Trials

Navigating Future Challenges in Alzheimer's Disease Trials

Tue, 21 Sep 2010 13:54:12 -0400

Quintiles’ own Alzheimer’s experts, Amir Kalali, Roza Hayduk and Lynne Hughes, sum up the insights and discoveries that could lead to the next breakthrough for Alzheimer’s disease.

Navigating Future Challenges in Alzheimer's Disease Trials

Tue, 21 Sep 2010 13:42:03 -0400

Watch the Welcome and Introduction video by event Chairman, Amir Kalali, M.D., Vice President, Medical & Scientific Services at Quintiles

Safety Strategy & Optimization

Tue, 14 Sep 2010 12:06:24 -0400

Learn how to enable your safety group to become a value-added contributor throughout the product lifecycle. Download the PDF

Re-energizing a Brand

Wed, 01 Sep 2010 14:06:53 -0400

Learn how Quintiles revamped the consumer marketing plan for an oral health product, boosting brand awareness by 90% and expanding the overall market size. Download the PDF

PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL

Tue, 31 Aug 2010 09:00:00 -0400

August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.

Mapping the Future in Oncology Drug Development

Fri, 27 Aug 2010 10:32:39 -0400

Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development

Biomarkers as an Approach to Improving Productivity in Oncology Drug Development

Thu, 19 Aug 2010 10:13:23 -0400

Richard Gaynor, MD of Eli Lilly presents Biomarkers as an Approach to Improving Productivity in Oncology Drug Development

New Pilot Examples Exploring these Novel Approaches

Fri, 13 Aug 2010 15:10:14 -0400

Daniel Haller, MD of the University of Pennsylvania Presents on New Pilot Examples Exploring these Novel Approaches.

Welcome and Introductory Remarks

Fri, 13 Aug 2010 14:58:43 -0400

Welcome and Introductory Remarks at Quintiles Ancillary Event at ASCO 2010

Behavior as an Outcome in Disease Modifying AD Trials

Fri, 06 Aug 2010 16:03:23 -0400

Watch the video of Jeffrey Cummings, M.D. of Cleveland Clinic recent presentation, Behaviors as an Outcome in Disease Modifying AD Trials from the Quintiles Symposium at ICAD 2010

Can Biomarkers Enhance Success Rates in Future AD Clinical Trials

Fri, 06 Aug 2010 15:57:30 -0400

Watch the video of Eric Siemer's recent presentation Can Biomarkers Enhance Success Rates in Future AD Clinical Trials at the Quintiles Symposium, Navigating Future Challenges in Alzheimer's Disease Trials at ICAD 2010

QUINTILES ANNOUNCES NEW EUROPEAN HEADQUARTERS

Thu, 29 Jul 2010 13:46:48 -0400

July 29, 2010 - Quintiles, announced that it is re-locating its European headquarters to within 30 minutes of Heathrow Airport at Green Park, Reading overlooking the M4 motorway.

Managing Pharmacovigilance as a Business

Wed, 28 Jul 2010 14:38:56 -0400

The three steps required to develop a strategic approach to global capacity management. Download the PDF

Executive Vision Forum 2010: Convergence of Data

Fri, 09 Jul 2010 00:11:09 -0400

Paul Mattes, Managing Director, Microsoft. Presentation about the convergence of data and technology at Executive Vision Forum 2010. Download the PDF

Executive Vision Forum 2010: Convergence of Stakeholders

Fri, 09 Jul 2010 00:08:04 -0400

A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders. Download the PDF

Executive Vision Forum 2010: Clinical and Commercial Convergence

Thu, 08 Jul 2010 23:58:38 -0400

Pasquale Cetera, VP Portfolio Management, Merck, presentation about the convergence of Clinical and Commercial. Download the PDF

Syndicated Solutions

Wed, 30 Jun 2010 12:03:23 -0400

Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk. Download the PDF

Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment

Wed, 30 Jun 2010 12:00:00 -0400

Brand Solutions

Tue, 08 Jun 2010 15:57:00 -0400

There are five practical ways you can use our Brand Solutions expertise to increase the value of your brand. Download the PDF

Targeting Oncology

Wed, 02 Jun 2010 15:36:02 -0400

Learn more about Quintiles leadership in oncology product development and commercialization. Download the PDF

Outsourcing as strategic alternative to your own headcount

Tue, 25 May 2010 08:32:08 -0400

Approach of Roche Italy in outsourcing their primary care sales force to Quintiles Download the PDF

Challenges in Conducting Trials in Alzheimer's Disease

Fri, 21 May 2010 09:39:29 -0400

This paper examines the opportunities for conducting clinical trials in Alzheimer's disease in low and middle income countries.

Philip Scheltens, MD

Thu, 20 May 2010 10:00:24 -0400

Prof. Dr. Philip Scheltens, VU Medical Center, Amsterdam Dr Philip Scheltens studied at the VU University Amsterdam, Netherlands

Amir Kalali, MD

Thu, 20 May 2010 09:04:06 -0400

Amir Kalali, MD Vice President, Medical and Scientific Services CNS Global Therapeutic Team Leader, Quintiles Amir Kalali, MD, is Vice President, Medical and Scientific Services,

QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT

Tue, 18 May 2010 00:00:00 -0400

May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program

Regulatory Landscapes for Future Antidiabetic Drug Development

Wed, 12 May 2010 15:36:59 -0400

In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk. Download the PDF

EMA’s Guidance on New Antidiabetic Drug Development

Wed, 12 May 2010 14:33:05 -0400

Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development

Navigating Future Challenges in Alzheimer's Disease Trials

Mon, 10 May 2010 13:04:28 -0400

Learn more about this exciting program

Global Flexibility

Sun, 09 May 2010 22:27:31 -0400

PharmaMar needed to mobilize an effective sales force covering a market that spanned several countries and 20 official languages. With Quintiles, on-time recruitment against aggressive timelines made it possible to top sales goals in the first year. Download the PDF

Blockbuster Co-Promotion

Sun, 09 May 2010 22:20:30 -0400

A pharma company targeted seven countries for quickly promoting its new compound. In just four months, Quintiles recruited, trained and implemented highly effective field sales teams in all seven new countries. Download the PDF

Agile Outsourcing

Sun, 09 May 2010 22:10:54 -0400

Read how Quintiles established a pan-European infrastructure, recruited senior management and was achieving KPIs across 12 countries in just eight months. Download the PDF

Bridging Cultures

Sun, 09 May 2010 21:48:09 -0400

Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise. Download the PDF

Focused Co-Promotion

Sun, 09 May 2010 21:39:20 -0400

Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth. Download the PDF

Podcast: Biopharma's Commercialization Challenges

Mon, 19 Apr 2010 09:29:41 -0400

Michael Ackermann, Ph.D., Vice President of Global Commercial Strategy and Alliance, Global Commercial Solutions at Quintiles, discusses the factors that are leading to a radical shift in how biopharmaceutical products are developed and commercialized.

FDA Requirements for Clinical Studies in Pediatric Patients

Thu, 01 Apr 2010 15:26:38 -0400

FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy Download the PDF

Propelling Pediatric Research

Thu, 01 Apr 2010 15:05:24 -0400

Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study Download the PDF

Boosting Pediatric Enrollment

Thu, 01 Apr 2010 14:54:03 -0400

Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks. Download the PDF

Commercial – Identify, Promote and Prove Treatment Value

Thu, 01 Apr 2010 09:16:42 -0400

Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. Download the PDF

The Power of Consolidation: How to Gain Efficiencies without Sacrificing Quality

Wed, 31 Mar 2010 12:00:00 -0400

Biopharma companies are outsourcing more clinical trial services for greater cost efficiencies. Quintiles provides integrated services with one point of contact and streamlined management. Download the PDF

Mapping the Future in Oncology Drug Development

Mon, 29 Mar 2010 12:21:45 -0400

A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development. Download the PDF

Integration of Molecular Biomarkers into Clinical Development

Mon, 29 Mar 2010 11:14:02 -0400

Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology. Download the PDF

QUINTILES EXAMINES ASIA-PACIFIC DRUG DEVELOPMENT LANDSCAPE IN NEW REPORT

Wed, 17 Mar 2010 06:00:00 -0400

March 17, 2010 - A new report from Quintiles analyzes the Asia-Pacific pharmaceutical development landscape and its evolution from outsourcing destination to potential innovation hub.

Regulations for Clinical Studies in Pediatric Patients in the European Union

Wed, 10 Mar 2010 14:36:34 -0400

After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric Download the PDF

Anticipating the Challenge

Wed, 03 Mar 2010 21:47:14 -0400

Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study. Download the PDF

Advancing Innovation

Wed, 03 Mar 2010 21:47:14 -0400

Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales. Download the PDF

Alzheimer's Inroads

Wed, 03 Mar 2010 21:34:48 -0400

A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site. Download the PDF

Trumping Expectations

Mon, 01 Mar 2010 14:40:30 -0400

Quintiles sails past recruitment hurdles with tailored approaches that build momentum Download the PDF

PharmAsia News Article Reprint

Mon, 01 Mar 2010 09:21:33 -0400

Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News. Download the PDF

Key Trends in Multiple Myeloma Treatment

Fri, 26 Feb 2010 11:30:43 -0400

An overview of the latest studies into novel drug combinations and new therapies in early stage testing in multiple myeloma. Download the PDF

Biomarker Trends in Breast Cancer Research

Wed, 24 Feb 2010 16:30:43 -0400

Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. Download the PDF

QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD

Mon, 14 Dec 2009 12:02:36 -0400

December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.

Shaping Clinical Transformation

Wed, 18 Nov 2009 00:02:11 -0400

A summary of key insights exchanged between pharma executives at the inaugural Quintiles Consulting Executive Vision Forum. Download the PDF

QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

Fri, 06 Nov 2009 10:47:04 -0400

November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH

Mon, 26 Oct 2009 11:53:57 -0400

October 26, 2009 - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London sign collaborative agreement with Quintiles.

QUINTILES CONSULTING EXPLORES IMPACT OF COMPARATIVE EFFECTIVENESS RESEARCH ON DRUG DEVELOPMENT

Wed, 21 Oct 2009 13:45:26 -0400

October 21, 2009 – John Doyle, Vice President and Practice Leader for Quintiles Consulting, calls for a standard set of Comparative Effectiveness Research (CER) Principles.

Rewarding Innovation and Value

Tue, 06 Oct 2009 12:44:04 -0400

The impact of comparative effectiveness research on the future of drug development. Download the PDF

QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS

Thu, 24 Sep 2009 11:39:33 -0400

September 24, 2009 - Quintiles Transnational Corp. announced the opening of an expanded regional facility near Edinburgh, Scotland; space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management.

QUINTILES ANNOUNCES CLINICAL RESEARCH PARNERSHIP WITH THE UNIVERSITY OF PRETORIA

Thu, 10 Sep 2009 13:54:23 -0400

September 10, 2009 – Quintiles Prime Site Program expands into South Africa to accelerate clinical development.

Sub-Saharan Africa Phase II/III Fact Sheet

Wed, 29 Jul 2009 11:37:27 -0400

Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. Download the PDF

Orphan Drugs in the U.S.

Wed, 24 Jun 2009 10:42:24 -0400

Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.” Download the PDF

Poised for success

Tue, 16 Jun 2009 17:56:39 -0400

Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility Download the PDF

Charting a New Course by Catalyzing Transformation

Tue, 09 Jun 2009 10:54:05 -0400

Adrian McKemey, Quintiles Consulting Product Development and Commercialization Practice Leader, and Michael Arlotto, Senior Vice President Corporate Development Quintiles, discuss how organizations are transforming their clinical organizations to more effectively deliver safer drugs.

The Importance of Latin America

Mon, 08 Jun 2009 10:16:44 -0400

Video showing why Latin America’s a great option for Clinical trials. With a total population over 500 million people and only two major languages, you will find a world of opportunity in the region.

India Today: Quintiles Central Laboratory

Mon, 08 Jun 2009 10:14:39 -0400

Video explaining why India’s a great option for clinical trials. Benefits include access to patients, potential cost savings, experienced investigators, and state of the art technology.

Rebalancing Risk to Transform R&D

Wed, 03 Jun 2009 10:32:40 -0400

A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource. Download the PDF

Placing Patients First

Tue, 26 May 2009 21:05:39 -0400

Regaining and restoring the public's trust in the pharmaceutical industry is of the utmost importance. Download the PDF

Anatomy of a Managed Partnership

Tue, 26 May 2009 20:55:45 -0400

Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs. Download the PDF

QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS

Mon, 25 May 2009 11:43:19 -0400

May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.

Making Headway in Shifting Winds by Maximizing Value

Fri, 01 May 2009 10:57:45 -0400

Three experts discuss how personalized medicine and more targeted therapies are causing organizations to change their commercial organizations.

Setting Sail for Success by Optimizing Productivity

Wed, 01 Apr 2009 11:06:10 -0400

Quintiles Consulting Market Intelligence (Eidetics) Practice Leader James Kirk and our process optimization expert Principal Consultant Mike Hagan discuss how you can optimize productivity in your organization.

A Testimonial About Quintiles Portugal

Mon, 30 Mar 2009 09:50:40 -0400

A testimonial about a commercial solution.

Contracting Timeline

Fri, 27 Mar 2009 16:44:36 -0400

Aggressive Recruitment Speeds Time to Market. The goal: to accelerate a study of a top-priority drug for non-myeloid malignancy. Quintiles ramped up 36 sites in just two months. Download the PDF

Robert A. Pearlstein

Wed, 25 Mar 2009 15:24:43 -0400

Bob is a co-founder of Eidetics, and has over two decades of experience assessing commercial opportunities and creating product strategies for biopharma and medical device clients worldwide.

George A. Mabry

Wed, 25 Mar 2009 15:21:43 -0400

George joined Eidetics in 1989 after a successful career in consumer and industrial products marketing and strategic planning. He previously held product management positions at General Foods and senior marketing management positions at Teradyne.

Frederick M. Gale, MD, FACS

Wed, 25 Mar 2009 15:15:30 -0400

A co-founder of Eidetics, Frederick brings over 20 years of experience in strategic research and consulting support for the pharmaceutical, biotech, and medical device industries.

Geoff Garabedian

Wed, 25 Mar 2009 15:08:35 -0400

As Practice Leader for Regulatory and Quality in the U.S., Geoff combines a strong management consulting background with specific experience in the regulatory and compliance arena, including design and implementation of large-scale process, organization and technology transformations.

Adrian McKemey, Ph.D.

Wed, 25 Mar 2009 13:52:40 -0400

Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting.

Jim Featherstone, Ph.D.

Wed, 25 Mar 2009 13:27:40 -0400

Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.

Matthew Eberhart

Wed, 25 Mar 2009 13:11:24 -0400

Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

Jay Norman

Tue, 24 Mar 2009 17:05:58 -0400

President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.

Gain Capital & Retain Value

Tue, 24 Mar 2009 13:30:18 -0400

Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product. Download the PDF

Jumpstarting a Phase III Candidate

Tue, 24 Mar 2009 12:54:16 -0400

A global pharmaceutical company had a promising new formulation of a marketed product in early Phase III trials, but R&D budget pressures were likely to result in delays getting the product to market. Download the PDF

Evidence-Based Development and Smarter Sourcing

Mon, 09 Mar 2009 11:22:16 -0400

Jay Norman, president of Quintiles Consulting, discusses the changing landscape of drug development and suggests that better, evidence-based decisions, combined with smart sourcing strategies, will differentiate the future winners. Download the PDF

Podcast: A New Gold Standard

Thu, 01 May 2008 14:58:56 -0400

John Doyle discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation. Download the PDF